Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer

Status unconfirmed · Phase 2

Conditions studied: Non-melanomatous Skin Cancer

In brief

RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, tumor cells are killed. This may be an effective treatment against skin cancer. PURPOSE: This phase II trial is studying the side effects of photodynamic therapy using aminolevulinic acid and to see how well it works in treating patients with skin cancer.

Key facts

Study ID

NCT00747903

Run by

Laser and Skin Surgery Center of New York

People needed

20

Starts

2008-02-01

Last updated by the study team

2014-01-10

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Laser and Skin Surgery Center of New York — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.